Abstract
Type 2 diabetes is a multifactorial disease that is caused by the disruption of inter-organ networks. These disruptions lead to absolute and/or relative deficiencies in the actions of insulin due to either a genetic disposition or environmental factors. Specifically, the liver plays a central role in energy homeostasis and is a major source of bioactive secretory proteins that contribute to the pathophysiology of diabetes and subsequent complications. Therefore, comprehensive gene expression analyses of critical tissues, including the liver, are important steps for understanding the molecular signature of type 2 diabetes. Serial analysis of gene expression (SAGE) techniques have made it possible to compare tag levels among independent libraries and to identify previously unrecognized genes with novel functions that may be important in the development of diseases. Here, we review possible applications of SAGE to the study of diabetes from the following perspectives: (1) to understand and quantify normal gene expression profiles in the liver with respect to both a single gene and gene ontology of cellular components; (2) to identify biological pathways or co-regulated gene sets associated with the pathophysiology of diabetes to gain a more comprehensive understanding of genetic and environmental alterations; and (3) to identify novel functional hepatic genes that may regulate the pathophysiology of diabetes by comparing independent SAGE libraries in combination with DNA chip analyses. Such SAGE-based approaches may lead to the identification of novel therapeutic targets for the treatment of type 2 diabetes and its complications.
Keywords: Type 2 diabetes, serial analysis of gene expression, liver, insulin resistance, mitochondrial oxidative phosphorylation, DNA chip
Current Pharmaceutical Biotechnology
Title: SAGE Application in the Study of Diabetes
Volume: 9 Issue: 5
Author(s): Toshinari Takamura, Hirofumi Misu, Taro Yamashita and Shuichi Kaneko
Affiliation:
Keywords: Type 2 diabetes, serial analysis of gene expression, liver, insulin resistance, mitochondrial oxidative phosphorylation, DNA chip
Abstract: Type 2 diabetes is a multifactorial disease that is caused by the disruption of inter-organ networks. These disruptions lead to absolute and/or relative deficiencies in the actions of insulin due to either a genetic disposition or environmental factors. Specifically, the liver plays a central role in energy homeostasis and is a major source of bioactive secretory proteins that contribute to the pathophysiology of diabetes and subsequent complications. Therefore, comprehensive gene expression analyses of critical tissues, including the liver, are important steps for understanding the molecular signature of type 2 diabetes. Serial analysis of gene expression (SAGE) techniques have made it possible to compare tag levels among independent libraries and to identify previously unrecognized genes with novel functions that may be important in the development of diseases. Here, we review possible applications of SAGE to the study of diabetes from the following perspectives: (1) to understand and quantify normal gene expression profiles in the liver with respect to both a single gene and gene ontology of cellular components; (2) to identify biological pathways or co-regulated gene sets associated with the pathophysiology of diabetes to gain a more comprehensive understanding of genetic and environmental alterations; and (3) to identify novel functional hepatic genes that may regulate the pathophysiology of diabetes by comparing independent SAGE libraries in combination with DNA chip analyses. Such SAGE-based approaches may lead to the identification of novel therapeutic targets for the treatment of type 2 diabetes and its complications.
Export Options
About this article
Cite this article as:
Takamura Toshinari, Misu Hirofumi, Yamashita Taro and Kaneko Shuichi, SAGE Application in the Study of Diabetes, Current Pharmaceutical Biotechnology 2008; 9 (5) . https://dx.doi.org/10.2174/138920108785915184
DOI https://dx.doi.org/10.2174/138920108785915184 |
Print ISSN 1389-2010 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4316 |
Call for Papers in Thematic Issues
Artificial Intelligence in Bioinformatics
Bioinformatics is an interdisciplinary field that analyzes and explores biological data. This field combines biology and information system. Artificial Intelligence (AI) has attracted great attention as it tries to replicate human intelligence. It has become common technology for analyzing and solving complex data and problems and encompasses sub-fields of machine ...read more
Latest Advancements in Biotherapeutics
The scope of this thematic issue is to comprehensively explore the rapidly evolving landscape of biotherapeutics, emphasizing breakthroughs in precision medicine. Encompassing diverse therapeutic modalities, the issue will delve into the latest developments in monoclonal antibodies, CRISPR/Cas gene editing, CAR-T cell therapies, and innovative drug delivery systems, such as nanoparticle-based ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Altered Hyaluronan Biosynthesis and Cancer Progression: an Immunological Perspective
Mini-Reviews in Medicinal Chemistry The Role of the Osteoimmune Axis in the Inflammation of the Inner Auditory Ear and with Regard to the Putative Anticarcinogenetic Principle: Part 2
Inflammation & Allergy - Drug Targets (Discontinued) Meta Analysis of Advanced Cancer Survival Data Using Lognormal Parametric Fitting: A Statistical Method to Identify Effective Treatment Protocols
Current Pharmaceutical Design Closing the Gap: An Atomistic Structural and Functional Perspective of S. <i>mansoni</i> Universal Stress G4LZI3 Protein in Complex with Phenolic Compounds
Current Drug Discovery Technologies Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds
Current Cancer Drug Targets Anticancer Properties of Essential Oils: An Overview
Current Cancer Drug Targets How is Gene Transfection Able to Improve Current Chemotherapy? The Role of Combined Therapy in Cancer Treatment
Current Medicinal Chemistry Anti-Gene IGF-I Vaccines in Cancer Gene Therapy: A Review of a Case of Glioblastoma
Current Medicinal Chemistry P2X Receptors, Sensory Neurons and Pain
Current Medicinal Chemistry Heparin - a Key Drug in the Treatment of the Circulatory Degenerative Diseases: Controlling its Action with Polymers
Current Pharmaceutical Design Withdrawal Notice: Characterization of Glyoxal Modified LDL: Role in the Generation of Circulating Autoantibodies in Type 2 Diabetes Mellitus and Coronary Artery Disease
Current Drug Targets Managing Comorbidity in COPD: A Difficult Task
Current Drug Targets Patent Selections
Recent Patents on Biotechnology Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future Perspectives
Current Drug Metabolism Nucleic Acid Carrier Systems Based on Polyethylenimine Conjugates for the Treatment of Metastatic Tumors
Current Medicinal Chemistry Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy
Current Molecular Pharmacology Photodynamic Therapy For Non-Melanoma Skin Cancers
Current Cancer Therapy Reviews Leucine-zipper and Sterile-α Motif Kinase (ZAK): A Potential Target for Drug Discovery
Current Medicinal Chemistry 1,2,3-Triazine Scaffold as a Potent Biologically Active Moiety: A Mini Review
Mini-Reviews in Medicinal Chemistry HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP): Still an Obscure Disease
Central Nervous System Agents in Medicinal Chemistry